The PAE group showed more overall adverse events and complications ( P = .029 ) , mostly related to acute urinary retention ( 25.9 % ) , postembolization syndrome ( 11.1 % ) , and treatment failures ( 5.3 % technical ; 9.4 % clinical ) .